3,020
Participants
Start Date
February 28, 2003
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
aspirin
Participants receive aspirin + placebo, specifically: aspirin (325 mg) with placebo (an inactive substance). Participants will take 1 of each pill a day until the end of the study.
clopidogrel
Participants will receive aspirin + clopidogrel, specifically: aspirin (325 mg) with clopidogrel (75 mg)-- Participants will take 1 of each pill a day until the end of the study.
Target of Blood Pressure
Participants will be assigned to one of 2 groups of blood pressure control. The difference between the two groups is the target level of systolic blood pressure-either 130-149 mmHg or below 130 mmHg; to do so, the scientists will use medications that are already in the market for blood pressure management.
placebo
an inactive substance
Columbia University Medical Center, New York
Helen Hayes Hospital, Haverstraw
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zuibrán, Mexico City
Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City
Rochester General Hospital, Rochester
University of Rochester, Rochester
Universidad de Santiago de Compostela, Facultad de Medicina y Odontologia, Santiago de Compostela
Hosp. de Girona Dr. Josep Trueta, Girona
Hospital La Paz, Madrid
Emory University, Grady Health System, Atlanta
Miami-University of Miami, Miller School of Medicine, Miami
University of Southern Alabama Stroke Center, Mobile
Vanderbilt University Medical Center, Nashville
Ohio State University, Division of Stroke, Columbus
Case Western, Cleveland
Metrohealth Medical Center, Cleveland
Antiguo Hospital Civil de Guadalajara, Guadalajara
Wayne State, Detroit
Henry Ford Hospital, Department of Neurology, Detroit
Mercy Medical Center-Ruan Neurology Clinical Research, Des Moines
Medical College of Wisconsin-Neurology, Milwaukee
Marshfield Clinic, Department of Neurology, Marshfield
Berman Center, Minneapolis
Mayo Stroke Center KA-SL-13, Rochester
Tenet Health, St. Louis University, St Louis
St. John's Mercy, St Louis
Scurlock Stroke Center, Houston
Catholic Healthcare West, Phoenix
Mayo Clinic Scottsdale, Scottsdale
University of Arizona, Department of Neurology, Tucson
Oregon Health and Science University, Portland
Hospital de La Universidad Autonoma de Nuevo Leon, Monterrey
Hospital Naval Almirante Nef, 'Subida Alessandri s/n, Hall A, Oficina 9, Viña del Mar
University of California San Diego Medical Center, San Diego
University of California San Francisco-Fresno, San Francisco-Fresno
Denver, Englewood
Melbourne, Melbourne
Suburban Hospital, Bethesda
University of Washington, Sant Louis
Buffalo, Buffalo
Hospital Clinico de la Universidad Católica de Chile, Santiago
Hospital-Clinica Kennedy, Guayaquil
Hospital Sabogal Essalud-Unidad de Investigacion, Bellavista-Callao
University of Kentucky, Aging/Stroke Program, Lexington
Boston University, Boston
Cooper University Hospital, Camden
Wake Forest University, Sciences-Neurology, Winston-Salem
University of Texas Southwestern, Dallas
University of Texas Health Science Center, San Antonio
University of Washington, Seattle
Calgary Health, Calgary
SPS3 Coordinating Center, Vancouver
Halifax, Halifax
Ottawa Hospital General Campus, Ottawa
Greenfield Park, Greenfield Park
McGill-Jewish General, Montreal
McGill-Montreal General, Montreal
CHA-Hospital de l'Enfant-Jesus, Québec
Hosp. Universitario Germans Trias I Pujol, Badalona
Hospital Del Mar, Passeig Marítim 25-29, Barcelona
Hospital de la Santa Creu I Sant Pau, c/Sant Antoni Maria Claret, 167, Barcelona
Hospital del Sagrat Cor. Quinta de Salut I'Alianca, c/Viladomat 288, Barcelona
Hosp. Parc Tauli de Sabadell, Barcelona
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
University of British Columbia
OTHER